ヘルペス治療の世界市場 2024-2028

Technavio社は、ヘルペス治療市場をモニターしており、2023年から2028年にかけて11億4,220万米ドル、予測期間中のCAGRは4.43%で成長すると予測しています。

当レポートでは、ヘルペス治療市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、ヘルペス感染症の有病率の増加、増加した患者、高齢者層における帯状疱疹の有病率の上昇によって牽引されています。

本調査では、今後数年間のヘルペス治療市場成長を牽引する主な要因の一つとして、新規治療法の出現を挙げています。また、ヘルペスのワクチン開発や安全な治療法開発の研究開発への注目が高まっていることも、市場の大きな需要につながっています。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム
• 市場の特徴
• バリューチェーン分析

第3章 市場規模の評価

• 市場の定義
• 市場セグメント分析
• 市場規模 2023
• 市場の見通し 2023-2028

第4章 市場規模実績

• 世界ヘルペス治療市場 2018-2022
• 製品別セグメント分析 2018-2022
• タイプ別セグメント分析 2018-2022
• 地域別セグメント分析 2018-2022
• 国別セグメント分析 2018-2022

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：製品別

• 市場セグメンテーション
• 比較：製品別
• 予防接種：市場規模と予測 2023-2028
• 薬物治療：市場規模と予測 2023-2028
• 市場機会：製品別

第7章 市場セグメンテーション：タイプ別

• 市場セグメンテーション
• 比較：タイプ別
• 帯状疱疹：市場規模と予測 2023-2028
• 単純ヘルペス：市場規模と予測 2023-2028
• 市場機会：タイプ別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2023-2028
• 欧州：市場規模と予測 2023-2028
• アジア：市場規模と予測 2023-2028
• 世界のその他の地域：市場規模と予測 2023-2028
• 米国：市場規模と予測 2023-2028
• 日本：市場規模と予測 2023-2028
• ドイツ：市場規模と予測 2023-2028
• フランス：市場規模と予測 2023-2028
• 英国：市場規模と予測 2023-2028
• 市場機会：地域別

第10章 促進要因・課題・機会・抑制要因

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場の機会・抑制要因

第11章 競合情勢

• 概要
• 競合情勢
• 混乱の状況
• 業界のリスク

第12章 競合分析

• 企業プロファイル
• 企業の市場ポジショニング
• AbbVie Inc.
• AiCuris Anti infective Cures AG
• Aurobindo Pharma Ltd.
• Cipla Inc.
• Eli Lilly and Co.
• Fresenius SE and Co. KGaA
• Gilead Sciences Inc.
• GlaxoSmithKline Plc
• Maruho Co. Ltd.
• Merck and Co. Inc.
• Novartis AG
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.
• Viatris Inc.
• Zydus Lifesciences Ltd.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market by Geography
• Exhibits5: Executive Summary - Chart on Market Segmentation by Product
• Exhibits6: Executive Summary - Chart on Market Segmentation by Type
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Company Market Positioning
• Exhibits10: Parent Market
• Exhibits11: Data Table on - Parent Market
• Exhibits12: Market characteristics analysis
• Exhibits13: Value Chain Analysis
• Exhibits14: Offerings of companies included in the market definition
• Exhibits15: Market segments
• Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits20: Historic Market Size - Data Table on Global Herpes Treatment Market 2018 - 2022 ($ million)
• Exhibits21: Historic Market Size - Product Segment 2018 - 2022 ($ million)
• Exhibits22: Historic Market Size - Type Segment 2018 - 2022 ($ million)
• Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• Exhibits25: Five forces analysis - Comparison between 2023 and 2028
• Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits31: Chart on Market condition - Five forces 2023 and 2028
• Exhibits32: Chart on Product - Market share 2023-2028 (%)
• Exhibits33: Data Table on Product - Market share 2023-2028 (%)
• Exhibits34: Chart on Comparison by Product
• Exhibits35: Data Table on Comparison by Product
• Exhibits36: Chart on Vaccination - Market size and forecast 2023-2028 ($ million)
• Exhibits37: Data Table on Vaccination - Market size and forecast 2023-2028 ($ million)
• Exhibits38: Chart on Vaccination - Year-over-year growth 2023-2028 (%)
• Exhibits39: Data Table on Vaccination - Year-over-year growth 2023-2028 (%)
• Exhibits40: Chart on Drug therapy - Market size and forecast 2023-2028 ($ million)
• Exhibits41: Data Table on Drug therapy - Market size and forecast 2023-2028 ($ million)
• Exhibits42: Chart on Drug therapy - Year-over-year growth 2023-2028 (%)
• Exhibits43: Data Table on Drug therapy - Year-over-year growth 2023-2028 (%)
• Exhibits44: Market opportunity by Product ($ million)
• Exhibits45: Data Table on Market opportunity by Product ($ million)
• Exhibits46: Chart on Type - Market share 2023-2028 (%)
• Exhibits47: Data Table on Type - Market share 2023-2028 (%)
• Exhibits48: Chart on Comparison by Type
• Exhibits49: Data Table on Comparison by Type
• Exhibits50: Chart on Herpes zoster - Market size and forecast 2023-2028 ($ million)
• Exhibits51: Data Table on Herpes zoster - Market size and forecast 2023-2028 ($ million)
• Exhibits52: Chart on Herpes zoster - Year-over-year growth 2023-2028 (%)
• Exhibits53: Data Table on Herpes zoster - Year-over-year growth 2023-2028 (%)
• Exhibits54: Chart on Herpes simplex - Market size and forecast 2023-2028 ($ million)
• Exhibits55: Data Table on Herpes simplex - Market size and forecast 2023-2028 ($ million)
• Exhibits56: Chart on Herpes simplex - Year-over-year growth 2023-2028 (%)
• Exhibits57: Data Table on Herpes simplex - Year-over-year growth 2023-2028 (%)
• Exhibits58: Market opportunity by Type ($ million)
• Exhibits59: Data Table on Market opportunity by Type ($ million)
• Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits61: Chart on Market share By Geographical Landscape2023-2028 (%)
• Exhibits62: Data Table on Market share By Geographical Landscape2023-2028 (%)
• Exhibits63: Chart on Geographic comparison
• Exhibits64: Data Table on Geographic comparison
• Exhibits65: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits66: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits67: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits68: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits69: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits70: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits71: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits72: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits73: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits74: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits75: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits76: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits81: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibits82: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibits83: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits84: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits85: Chart on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibits86: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibits87: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibits88: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• Exhibits89: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits90: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits91: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits92: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits93: Chart on France - Market size and forecast 2023-2028 ($ million)
• Exhibits94: Data Table on France - Market size and forecast 2023-2028 ($ million)
• Exhibits95: Chart on France - Year-over-year growth 2023-2028 (%)
• Exhibits96: Data Table on France - Year-over-year growth 2023-2028 (%)
• Exhibits97: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits98: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits99: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits100: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits101: Market opportunity By Geographical Landscape($ million)
• Exhibits102: Data Tables on Market opportunity By Geographical Landscape($ million)
• Exhibits103: Impact of drivers and challenges in 2023 and 2028
• Exhibits104: Overview on criticality of inputs and factors of differentiation
• Exhibits105: Overview on factors of disruption
• Exhibits106: Impact of key risks on business
• Exhibits107: Companies covered
• Exhibits108: Matrix on companies position and classification
• Exhibits109: AbbVie Inc. - Overview
• Exhibits110: AbbVie Inc. - Product / Service
• Exhibits111: AbbVie Inc. - Key news
• Exhibits112: AbbVie Inc. - Key offerings
• Exhibits113: AiCuris Anti infective Cures AG - Overview
• Exhibits114: AiCuris Anti infective Cures AG - Product / Service
• Exhibits115: AiCuris Anti infective Cures AG - Key offerings
• Exhibits116: Aurobindo Pharma Ltd. - Overview
• Exhibits117: Aurobindo Pharma Ltd. - Product / Service
• Exhibits118: Aurobindo Pharma Ltd. - Key offerings
• Exhibits119: Cipla Inc. - Overview
• Exhibits120: Cipla Inc. - Business segments
• Exhibits121: Cipla Inc. - Key offerings
• Exhibits122: Cipla Inc. - Segment focus
• Exhibits123: Eli Lilly and Co. - Overview
• Exhibits124: Eli Lilly and Co. - Product / Service
• Exhibits125: Eli Lilly and Co. - Key news
• Exhibits126: Eli Lilly and Co. - Key offerings
• Exhibits127: Fresenius SE and Co. KGaA - Overview
• Exhibits128: Fresenius SE and Co. KGaA - Business segments
• Exhibits129: Fresenius SE and Co. KGaA - Key news
• Exhibits130: Fresenius SE and Co. KGaA - Key offerings
• Exhibits131: Fresenius SE and Co. KGaA - Segment focus
• Exhibits132: Gilead Sciences Inc. - Overview
• Exhibits133: Gilead Sciences Inc. - Product / Service
• Exhibits134: Gilead Sciences Inc. - Key offerings
• Exhibits135: GlaxoSmithKline Plc - Overview
• Exhibits136: GlaxoSmithKline Plc - Business segments
• Exhibits137: GlaxoSmithKline Plc - Key news
• Exhibits138: GlaxoSmithKline Plc - Key offerings
• Exhibits139: GlaxoSmithKline Plc - Segment focus
• Exhibits140: Maruho Co. Ltd. - Overview
• Exhibits141: Maruho Co. Ltd. - Product / Service
• Exhibits142: Maruho Co. Ltd. - Key news
• Exhibits143: Maruho Co. Ltd. - Key offerings
• Exhibits144: Merck and Co. Inc. - Overview
• Exhibits145: Merck and Co. Inc. - Business segments
• Exhibits146: Merck and Co. Inc. - Key news
• Exhibits147: Merck and Co. Inc. - Key offerings
• Exhibits148: Merck and Co. Inc. - Segment focus
• Exhibits149: Novartis AG - Overview
• Exhibits150: Novartis AG - Business segments
• Exhibits151: Novartis AG - Key news
• Exhibits152: Novartis AG - Key offerings
• Exhibits153: Novartis AG - Segment focus
• Exhibits154: Sun Pharmaceutical Industries Ltd. - Overview
• Exhibits155: Sun Pharmaceutical Industries Ltd. - Product / Service
• Exhibits156: Sun Pharmaceutical Industries Ltd. - Key news
• Exhibits157: Sun Pharmaceutical Industries Ltd. - Key offerings
• Exhibits158: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibits159: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibits160: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibits161: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibits162: Teva Pharmaceutical Industries Ltd. - Segment focus
• Exhibits163: Viatris Inc. - Overview
• Exhibits164: Viatris Inc. - Business segments
• Exhibits165: Viatris Inc. - Key news
• Exhibits166: Viatris Inc. - Key offerings
• Exhibits167: Viatris Inc. - Segment focus
• Exhibits168: Zydus Lifesciences Ltd. - Overview
• Exhibits169: Zydus Lifesciences Ltd. - Business segments
• Exhibits170: Zydus Lifesciences Ltd. - Key news
• Exhibits171: Zydus Lifesciences Ltd. - Key offerings
• Exhibits172: Zydus Lifesciences Ltd. - Segment focus
• Exhibits173: Inclusions checklist
• Exhibits174: Exclusions checklist
• Exhibits175: Currency conversion rates for US$
• Exhibits176: Research methodology
• Exhibits177: Information sources
• Exhibits178: Data validation
• Exhibits179: Validation techniques employed for market sizing
• Exhibits180: Data synthesis
• Exhibits181: 360 degree market analysis
• Exhibits182: List of abbreviations

Technavio has been monitoring the herpes treatment market and is forecast to grow by USD 1142.2 mn during 2023-2028, accelerating at a CAGR of 4.43% during the forecast period. Our report on the herpes treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of herpes infection, large patient pool, and rising prevalence rate of shingles in older population.

Technavio's herpes treatment market is segmented as below:

By Product

• Vaccination
• Drug therapy

By Type

• Herpes zoster
• Herpes simplex

By Geography

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the emergence of novel therapies as one of the prime reasons driving the herpes treatment market growth during the next few years. Also, increasing focus on vaccine development and increasing research on developing safe treatment for herpes will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the herpes treatment market covers the following areas:

• Herpes treatment market sizing
• Herpes treatment market forecast
• Herpes treatment market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading herpes treatment market vendors that include AbbVie Inc., AiCuris Anti infective Cures AG, Aurobindo Pharma Ltd., Avet Pharmaceuticals Inc., Bausch Health Companies Inc., CENTURION REMEDIES Pvt. Ltd., Cipla Inc., Eli Lilly and Co., Fresenius SE and Co. KGaA, Gilead Sciences Inc., GlaxoSmithKline Plc, Maruho Co. Ltd., Merck and Co. Inc., Novartis AG, Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., Zeelab Laboratories Ltd., and Zydus Lifesciences Ltd.. Also, the herpes treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 2.2 Market characteristics
  • Market characteristics analysis
• 2.3 Value chain analysis
  • Value Chain Analysis

3 Market Sizing

• 3.1 Market definition
  • Offerings of companies included in the market definition
• 3.2 Market segment analysis
  • Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global Herpes Treatment Market 2018 - 2022
  • Historic Market Size - Data Table on Global Herpes Treatment Market 2018 - 2022 ($ million)
• 4.2 Product segment analysis 2018 - 2022
  • Historic Market Size - Product Segment 2018 - 2022 ($ million)
• 4.3 Type segment analysis 2018 - 2022
  • Historic Market Size - Type Segment 2018 - 2022 ($ million)
• 4.4 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

• 6.1 Market segments
  • Chart on Product - Market share 2023-2028 (%)
  • Data Table on Product - Market share 2023-2028 (%)
• 6.2 Comparison by Product
  • Chart on Comparison by Product
  • Data Table on Comparison by Product
• 6.3 Vaccination - Market size and forecast 2023-2028
  • Chart on Vaccination - Market size and forecast 2023-2028 ($ million)
  • Data Table on Vaccination - Market size and forecast 2023-2028 ($ million)
  • Chart on Vaccination - Year-over-year growth 2023-2028 (%)
  • Data Table on Vaccination - Year-over-year growth 2023-2028 (%)
• 6.4 Drug therapy - Market size and forecast 2023-2028
  • Chart on Drug therapy - Market size and forecast 2023-2028 ($ million)
  • Data Table on Drug therapy - Market size and forecast 2023-2028 ($ million)
  • Chart on Drug therapy - Year-over-year growth 2023-2028 (%)
  • Data Table on Drug therapy - Year-over-year growth 2023-2028 (%)
• 6.5 Market opportunity by Product
  • Market opportunity by Product ($ million)
  • Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Type

• 7.1 Market segments
  • Chart on Type - Market share 2023-2028 (%)
  • Data Table on Type - Market share 2023-2028 (%)
• 7.2 Comparison by Type
  • Chart on Comparison by Type
  • Data Table on Comparison by Type
• 7.3 Herpes zoster - Market size and forecast 2023-2028
  • Chart on Herpes zoster - Market size and forecast 2023-2028 ($ million)
  • Data Table on Herpes zoster - Market size and forecast 2023-2028 ($ million)
  • Chart on Herpes zoster - Year-over-year growth 2023-2028 (%)
  • Data Table on Herpes zoster - Year-over-year growth 2023-2028 (%)
• 7.4 Herpes simplex - Market size and forecast 2023-2028
  • Chart on Herpes simplex - Market size and forecast 2023-2028 ($ million)
  • Data Table on Herpes simplex - Market size and forecast 2023-2028 ($ million)
  • Chart on Herpes simplex - Year-over-year growth 2023-2028 (%)
  • Data Table on Herpes simplex - Year-over-year growth 2023-2028 (%)
• 7.5 Market opportunity by Type
  • Market opportunity by Type ($ million)
  • Data Table on Market opportunity by Type ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape2023-2028 (%)
  • Data Table on Market share By Geographical Landscape2023-2028 (%)
• 9.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Japan - Market size and forecast 2023-2028
  • Chart on Japan - Market size and forecast 2023-2028 ($ million)
  • Data Table on Japan - Market size and forecast 2023-2028 ($ million)
  • Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 9.9 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.10 France - Market size and forecast 2023-2028
  • Chart on France - Market size and forecast 2023-2028 ($ million)
  • Data Table on France - Market size and forecast 2023-2028 ($ million)
  • Chart on France - Year-over-year growth 2023-2028 (%)
  • Data Table on France - Year-over-year growth 2023-2028 (%)
• 9.11 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity by geography
  • Market opportunity By Geographical Landscape($ million)
  • Data Tables on Market opportunity By Geographical Landscape($ million)

10 Drivers, Challenges, and Opportunity/Restraints

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
• 10.4 Market opportunities/restraints

11 Competitive Landscape

• 11.1 Overview
• 11.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 11.3 Landscape disruption
  • Overview on factors of disruption
• 11.4 Industry risks
  • Impact of key risks on business

12 Competitive Analysis

• 12.1 Companies profiled
  • Companies covered
• 12.2 Market positioning of companies
  • Matrix on companies position and classification
• 12.3 AbbVie Inc.
  • AbbVie Inc. - Overview
  • AbbVie Inc. - Product / Service
  • AbbVie Inc. - Key news
  • AbbVie Inc. - Key offerings
• 12.4 AiCuris Anti infective Cures AG
  • AiCuris Anti infective Cures AG - Overview
  • AiCuris Anti infective Cures AG - Product / Service
  • AiCuris Anti infective Cures AG - Key offerings
• 12.5 Aurobindo Pharma Ltd.
  • Aurobindo Pharma Ltd. - Overview
  • Aurobindo Pharma Ltd. - Product / Service
  • Aurobindo Pharma Ltd. - Key offerings
• 12.6 Cipla Inc.
  • Cipla Inc. - Overview
  • Cipla Inc. - Business segments
  • Cipla Inc. - Key offerings
  • Cipla Inc. - Segment focus
• 12.7 Eli Lilly and Co.
  • Eli Lilly and Co. - Overview
  • Eli Lilly and Co. - Product / Service
  • Eli Lilly and Co. - Key news
  • Eli Lilly and Co. - Key offerings
• 12.8 Fresenius SE and Co. KGaA
  • Fresenius SE and Co. KGaA - Overview
  • Fresenius SE and Co. KGaA - Business segments
  • Fresenius SE and Co. KGaA - Key news
  • Fresenius SE and Co. KGaA - Key offerings
  • Fresenius SE and Co. KGaA - Segment focus
• 12.9 Gilead Sciences Inc.
  • Gilead Sciences Inc. - Overview
  • Gilead Sciences Inc. - Product / Service
  • Gilead Sciences Inc. - Key offerings
• 12.10 GlaxoSmithKline Plc
  • GlaxoSmithKline Plc - Overview
  • GlaxoSmithKline Plc - Business segments
  • GlaxoSmithKline Plc - Key news
  • GlaxoSmithKline Plc - Key offerings
  • GlaxoSmithKline Plc - Segment focus
• 12.11 Maruho Co. Ltd.
  • Maruho Co. Ltd. - Overview
  • Maruho Co. Ltd. - Product / Service
  • Maruho Co. Ltd. - Key news
  • Maruho Co. Ltd. - Key offerings
• 12.12 Merck and Co. Inc.
  • Merck and Co. Inc. - Overview
  • Merck and Co. Inc. - Business segments
  • Merck and Co. Inc. - Key news
  • Merck and Co. Inc. - Key offerings
  • Merck and Co. Inc. - Segment focus
• 12.13 Novartis AG
  • Novartis AG - Overview
  • Novartis AG - Business segments
  • Novartis AG - Key news
  • Novartis AG - Key offerings
  • Novartis AG - Segment focus
• 12.14 Sun Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Ltd. - Overview
  • Sun Pharmaceutical Industries Ltd. - Product / Service
  • Sun Pharmaceutical Industries Ltd. - Key news
  • Sun Pharmaceutical Industries Ltd. - Key offerings
• 12.15 Teva Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd. - Overview
  • Teva Pharmaceutical Industries Ltd. - Business segments
  • Teva Pharmaceutical Industries Ltd. - Key news
  • Teva Pharmaceutical Industries Ltd. - Key offerings
  • Teva Pharmaceutical Industries Ltd. - Segment focus
• 12.16 Viatris Inc.
  • Viatris Inc. - Overview
  • Viatris Inc. - Business segments
  • Viatris Inc. - Key news
  • Viatris Inc. - Key offerings
  • Viatris Inc. - Segment focus
• 12.17 Zydus Lifesciences Ltd.
  • Zydus Lifesciences Ltd. - Overview
  • Zydus Lifesciences Ltd. - Business segments
  • Zydus Lifesciences Ltd. - Key news
  • Zydus Lifesciences Ltd. - Key offerings
  • Zydus Lifesciences Ltd. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 13.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 13.4 Research methodology
  • Research methodology
• 13.5 Data procurement
  • Information sources
• 13.6 Data validation
  • Data validation
• 13.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 13.8 Data synthesis
  • Data synthesis
• 13.9 360 degree market analysis
  • 360 degree market analysis
• 13.10 List of abbreviations
  • List of abbreviations